Department of Pediatrics.
Department of Hepatology of the Unversity Hospitals.
J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):720-725. doi: 10.1097/MPG.0000000000002894.
Since 2005, a New Wilson Index (NWI) ≥11 is used as a predictor of death without transplantation in fulminant Wilson disease (WD). Plasma exchange is advocated as a new treatment modality.
We present a patient with fulminant WD treated with plasma exchange. All published cases applying plasma exchange for fulminant WD were reviewed systematically.
A 14-year-old girl presented with hemolysis and fulminant liver failure. She had no encephalopathy; NWI was 14. As a bridge to transplantation plasma exchange was started immediately. Complete remission was achieved with plasma exchange and later chelation therapy with D-penicillamine. She is now at 3-year transplant-free survival. Literature review identified 37 patients presenting with fulminant WD and NWI ≥11 who were treated with plasma exchange. Seventeen of these patients (ie, 46%) recovered without transplantation.
Multiple case reports and case series demonstrate transplant free survival after plasma exchange and subsequent chelation therapy, despite a NWI ≥11. Plasma exchange affects the clinical course and is a therapeutic option in children and young adults presenting with fulminant WD.
自 2005 年以来,新的威尔逊指数(NWI)≥11 被用作暴发性肝豆状核变性(WD)患者无移植死亡的预测因子。提倡血浆置换作为一种新的治疗方式。
我们介绍了一位接受血浆置换治疗的暴发性 WD 患者。系统回顾了所有应用血浆置换治疗暴发性 WD 的已发表病例。
一名 14 岁女孩因溶血性贫血和暴发性肝功能衰竭就诊。她没有脑病;NWI 为 14。作为肝移植的桥梁,立即开始进行血浆置换。完全缓解是通过血浆置换和随后的 D-青霉胺螯合疗法实现的。目前,她无肝移植生存 3 年。文献复习发现,37 例 NWI≥11 的暴发性 WD 患者接受了血浆置换治疗。其中 17 例(46%)未经移植而康复。
多项病例报告和病例系列研究表明,尽管 NWI≥11,但在接受血浆置换和随后的螯合治疗后可实现无移植生存。血浆置换影响疾病进程,是儿童和年轻成人暴发性 WD 的一种治疗选择。